Syntagma Capital is a private equity firm based in Brussels focused on investing in industrial and business-to-business companies across Europe, including the chemicals and materials value chains. The firm targets corporate carve‑outs, divisional spin‑offs, and other complex transactions where operational change and strategic repositioning are required.
In chemicals and adjacent sectors, Syntagma Capital backs businesses involved in specialty chemicals, intermediates, formulated products, and related manufacturing and distribution. Its approach emphasizes hands‑on operational support, portfolio optimization, and selective buy‑and‑build strategies to improve scale, efficiency, and profitability. The firm typically works closely with management teams to enhance manufacturing performance, supply chains, product portfolios, and regulatory and EHS practices.
Syntagma Capital invests across Western and Central Europe and selectively in other regions, aiming to create resilient, stand‑alone companies with clear strategic direction and strong governance.
Stahl halts sale to Syntagma Capital due to market conditions, continuing the carve-out to form a new brand, Muno, focusing on speciality coatings and innovation.
